KALA BIO, Inc. SEC filings KALA
KALA BIO, Inc. has 675 filings in SEC EDGAR's recent list, going back to Dec 23, 2009. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Shareholder vote results
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 10, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Other events
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 28, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Other events
|
Jul 23, 2026 | Jul 22, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Mar 4, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 20, 2026 | Feb 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Feb 2, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Listing notice
|
Jan 23, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Material agreement
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 6, 2026 | Dec 30, 2025 |
| 8-K |
Current report
Other events
|
Jan 2, 2026 | Dec 26, 2025 |
| 8-K |
Current report
Auditor change, Officer or director change
|
Dec 29, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Auditor change
|
Dec 16, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Other events
|
Dec 16, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 5, 2025 | Dec 4, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Officer or director change, Bylaw or fiscal year change
|
Nov 25, 2025 | Nov 20, 2025 |
| 8-K |
Current report
Listing notice
|
Nov 12, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Nov 10, 2025 | Nov 9, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Other events
|
Oct 20, 2025 | Oct 19, 2025 |
| 8-K/A |
Amended current report
Exit or restructuring costs, Officer or director change
|
Oct 2, 2025 | Sep 28, 2025 |
| 8-K | Current report | Oct 1, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Sep 29, 2025 | Sep 28, 2025 |
| 8-K |
Current report
Other events
|
Sep 18, 2025 | Sep 16, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2025 | Aug 29, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Other events
|
Jul 9, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 11, 2025 | Apr 10, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 12, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Dec 30, 2024 | Dec 29, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 25, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Jun 27, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2024 | Mar 29, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Mar 26, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Dec 22, 2023 | Dec 21, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2023 | Aug 4, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 2, 2023 | Aug 2, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 23, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Other events
|
Apr 28, 2023 | Apr 28, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Apr 25, 2023 | Apr 24, 2023 |
| 8-K |
Current report
Other events
|
Mar 27, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2023 | Mar 3, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 19, 2023 | Jan 18, 2023 |
| 8-K |
Current report
Other events
|
Jan 10, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Dec 27, 2022 | Dec 27, 2022 |
| 8-K |
Current report
Listing notice
|
Dec 9, 2022 | Dec 5, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Nov 28, 2022 | Nov 28, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 1, 2022 | Oct 31, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Oct 20, 2022 | Oct 19, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 19, 2022 | Aug 18, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K/A | Amended current report | Jul 12, 2022 | Jul 8, 2022 |
| 8-K |
Current report
Acquisition or sale of assets, Exit or restructuring costs, Listing notice, Other events
|
Jul 8, 2022 | Jul 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Listing notice
|
May 27, 2022 | May 24, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
May 23, 2022 | May 21, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2022 | Mar 29, 2022 |
| 8-K |
Current report
Other events
|
Mar 22, 2022 | Mar 22, 2022 |
| 8-K |
Current report
Listing notice
|
Mar 4, 2022 | Mar 2, 2022 |
| 8-K/A | Amended current report | Jan 28, 2022 | Nov 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 20, 2021 | Dec 16, 2021 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Results of operations, Unregistered share sale, Officer or director change
|
Nov 15, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 18, 2021 | Oct 14, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Results of operations
|
May 5, 2021 | May 5, 2021 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
May 5, 2021 | May 4, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 7, 2021 | Jan 7, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 27, 2020 | Oct 27, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 17, 2020 | Sep 17, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 26, 2020 | Jun 25, 2020 |
| 8-K |
Current report
Other events
|
May 26, 2020 | May 26, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 8, 2020 | Apr 8, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 12, 2020 | Mar 10, 2020 |
| 8-K |
Current report
Other events
|
Mar 11, 2020 | Mar 10, 2020 |
| 8-K |
Current report
Other events
|
Mar 9, 2020 | Mar 9, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2020 | Feb 12, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Other events
|
Aug 8, 2019 | Aug 8, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2019 | Aug 6, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2019 | Jun 5, 2019 |
| 8-K |
Current report
Results of operations
|
May 9, 2019 | May 9, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2019 | Mar 11, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2019 | Jan 7, 2019 |
| 8-K |
Current report
Officer or director change
|
Dec 20, 2018 | Dec 19, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2018 | Nov 8, 2018 |
| 8-K |
Current report
Officer or director change
|
Nov 1, 2018 | Oct 29, 2018 |
| 8-K |
Current report
Other events
|
Oct 16, 2018 | Oct 16, 2018 |
| 8-K |
Current report
Other events
|
Oct 11, 2018 | Oct 11, 2018 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 5, 2018 | Oct 2, 2018 |
| 8-K |
Current report
Other events
|
Oct 2, 2018 | Oct 2, 2018 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Change to shareholder rights, Regulation FD disclosure
|
Oct 2, 2018 | Oct 1, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 5, 2018 | Sep 5, 2018 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 23, 2018 | Aug 23, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 15, 2018 | Aug 15, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2018 | Aug 9, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2018 | Jun 12, 2018 |
| 8-K |
Current report
Results of operations
|
May 10, 2018 | May 10, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2018 | Mar 26, 2018 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 12, 2018 | Mar 8, 2018 |
| 8-K |
Current report
Officer or director change
|
Mar 5, 2018 | Feb 28, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2018 | Jan 8, 2018 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 5, 2018 | Jan 5, 2018 |
| 8-K |
Current report
Officer or director change
|
Nov 13, 2017 | Nov 8, 2017 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2017 | Nov 7, 2017 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2017 | Sep 28, 2017 |
| 8-K |
Current report
Officer or director change
|
Aug 11, 2017 | Aug 7, 2017 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 25, 2017 | Jul 25, 2017 |
Showing 126 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KALA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Arlington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1479419
- Former names
- KALA BIO, Inc. (until Nov 3, 2026); Kala Pharmaceuticals, Inc. (until Jun 23, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.